Results 1 to 10 of about 14,387 (130)
Brazilian Journal of Nephrology, 2023 Membranous nephropathy is a glomerulopathy, which main affected target is the podocyte, and has consequences on the glomerular basement membrane. It is more common in adults, especially over 50 years of age.
Márcio Dantas +5 more
doaj +5 more sources
Nature Reviews Disease Primers, 2021 Membranous nephropathy (MN) is a glomerular disease that can occur at all ages. In adults, it is the most frequent cause of nephrotic syndrome. In ~80% of patients, there is no underlying cause of MN (primary MN) and the remaining cases are associated with medications or other diseases such as systemic lupus erythematosus, hepatitis virus infection or ...
Ronco, Pierre +9 more
+11 more sources
Lupus Membranous Nephropathy [PDF]
Glomerular Diseases, 2021 <b><i>Background:</i></b> Lupus membranous nephropathy (LMN) is a rare disease, usually associated with nephrotic syndrome. <b><i>Methods:</i></b> We reviewed the literature by searching for the following terms on Pubmed.gov: lupus nephritis, membranous nephropathy (MN), lupus membranous nephropathy ...
Ponticelli, Claudio +2 more
openaire +2 more sources
Journal of the Royal College of Physicians of London, 1997 link_to_subscribed_fulltext
Simon C Satchell, Peter W Mathieson
openaire +6 more sources
Case report: Successful treatment of refractory membranous nephropathy with telitacicept
Frontiers in Immunology, 2023 Despite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma
Lei Zhang +3 more
doaj +1 more source
Kidney Medicine, 2021 Technological advances have allowed the discovery of 6 subtypes of membranous nephropathy based on target antigens: M-type phospholipase A2 receptor (PLA2R), thrombospondin type 1 domain-containing 7A (THSD7A), neural epidermal growth factor-like 1 ...
Takamasa Iwakura +7 more
doaj +1 more source
The Efficacy of Rituximab in the Treatment of Membranous Nephropathy
Journal of Nepal Health Research Council, 2021 Rituximab is a chimeric monoclonal antibody directed against the CD20 expressed on B cells, originally used to treat lymphoma but is increasingly used for the treatment of autoimmune diseases.
Ruby Maharjan +2 more
doaj +1 more source
The value of repeat kidney biopsy during an atypical course of membranous nephropathy
BMC Nephrology, 2022 Background The clinical trajectory for patients with primary membranous nephropathy ranges widely from spontaneous remission to a rapid decline in kidney function.
Sumaiya Ahmed +5 more
doaj +1 more source
Treatment of membranous nephropathy [PDF]
Nephrology Dialysis Transplantation, 2001 Several therapeutic approaches have been tried in patients with membranous nephropathy. Corticosteroids have been largely used, but a meta-analysis of the available controlled trials did not show any benefit of corticosteroids either in favouring remission of the nephrotic syndrome or in preventing renal dysfunction.
Passerini Patrizia, Ponticelli Claudio
openaire +4 more sources
Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more [PDF]
Journal of Nephropathology, 2018 Context: Membranous nephropathy is among the most common causes of nephrotic syndrome in adults. Evidence Acquisitions: PubMed, EBSCO, Web of Science, directory of open access journals (DOAJ), EMBASE, and Google Scholar with keywords of phospholipase A2 ...
Bahar Bastani
doaj +1 more source